Lipisafe CV 10 Capsule is a combination medication containing Atorvastatin 10 mg and Clopidogrel 75 mg, indicated for the management of cardiovascular conditions requiring lipid control and antiplatelet therapy. Atorvastatin, a statin class agent, functions by inhibiting HMG-CoA reductase, thereby reducing cholesterol synthesis and lowering low-density lipoprotein (LDL) cholesterol levels, which contributes to the prevention of atherosclerotic plaque formation. Clopidogrel, an antiplatelet agent, irreversibly inhibits the P2Y12 component of ADP receptors on platelet surfaces, preventing platelet aggregation and reducing the risk of thrombotic events such as myocardial infarction and stroke. Lipisafe CV 10 Capsule is primarily prescribed for patients with established coronary artery disease, peripheral arterial disease, or those at high risk of cardiovascular events, requiring both lipid-lowering and antiplatelet effects. The combined formulation enhances patient compliance by simplifying therapy regimens. Caution is advised in patients with active bleeding, hepatic impairment, or hypersensitivity to either component. Regular monitoring of liver function tests and complete blood counts is recommended during therapy. Lipisafe CV 10 Capsule should be used under medical supervision, with attention to potential drug interactions and contraindications to optimize cardiovascular risk reduction.